# A Twelve Week Safety and Efficacy Study in Rosacea

> **NCT01784133** · PHASE2 · COMPLETED · sponsor: **Maruho Co., Ltd.** · enrollment: 240 (actual)

## Conditions studied

- Papulopustular Rosacea

## Interventions

- **DRUG:** omiganan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01784133
- **Lead sponsor:** Maruho Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2014-03
- **Final completion:** —
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2015-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01784133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01784133, "A Twelve Week Safety and Efficacy Study in Rosacea". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01784133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*